02496.HK
Wuhan YZY Biopharma Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.30
−8.33%Leverage
- Debt / equity
- -2.41x
- Net debt / equity
- -0.52x
- Debt / assets
- 0.73x
- Debt / EBITDA
- -1.43x
- Net debt / EBITDA
- -0.31x
Liquidity & coverage
- Current ratio
- 0.66x
- Quick ratio
- 0.64x
- Cash ratio
- 0.50x
- Interest coverage
- -22.48x
- EBITDA / interest
- -20.25x
- Working capital
- -HKD 80.0M
Cash & dividend
- FCF / debt
- -0.32x
- Cash flow / debt
- -0.31x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Dec 1, 2025